Applying an AMAD of 5 μm and a 232Th decay series to 238+235U decay series ratio of 101, committed effective doses to the workforce are greater by a factor of between 0.74 and 1.26 times from those reported in 2018-19 as a result of the revised DCs published in ICRP-137 and ICRP-141. Guidance on how to calculate doses from the inhalation of radioactive dusts is provided in the regulatory authority's Guideline 'NORM-5 Dose Assessment', which will need revision to incorporate the revised dose coefficients. The Guideline has been widely distributed outside of Western Australia, and those jurisdictions which have adopted all, or sections of it, into their legal framework for radiation protection may need to consider the impact of the revision.During transcatheter aortic valve implantations (TAVI) and other percutaneous structural procedures, some patients may need close anesthesiological care, thus exposing the anaesthesiologist to x-rays. This work aims to investigate the radiation dose received by anaesthesiologists during these specific procedures in order to improve their radiological protection. Occupational radiation doses were measured prospectively during percutaneous structural procedures in several health professionals using electronic dosimeters worn over the apron at chest level. A sample of 49 procedures were recorded, where the anaesthesiologists' average dose per procedure resulted 13 times higher than that of interventional cardiologists. The average dose per procedure received over the protection apron during TAVIs by the anaesthesiologist was 0.13 mSv, with a maximum value of 0.69 mSv. learn more Taking these figures as a conservative estimation of the eye lens dose, an anaesthesiologist could participate in around 150 procedures before reaching the regulatory annual dose limit for the lens of the eye in Europe (20 mSv). In those clinical procedures where patients need close anesthesiological care, the anaesthesiologists might receive high radiation doses increasing the risk for cataracts and the risk of stochastic radiation effects. The proper use of occupational dosimeters will help identify these situations. It is recommended to use a mobile shielding barrier to reduce radiation exposure to acceptable levels in these situations. To evaluate the potential of intracortical electrode array signals for brain-computer interfaces (BCIs) to restore lost speech, we measured the performance of decoders trained to discriminate a comprehensive basis set of 39 English phonemes and to synthesize speech sounds via a neural pattern matching method. We decoded neural correlates of spoken-out-loud words in the 'hand knob' area of precentral gyrus, a step toward the eventual goal of decoding attempted speech from ventral speech areas in patients who are unable to speak. Neural and audio data were recorded while two BrainGate2 pilot clinical trial participants, each with two chronically-implanted 96-electrode arrays, spoke 420 different words that broadly sampled English phonemes. Phoneme onsets were identified from audio recordings, and their identities were then classified from neural features consisting of each electrode's binned action potential counts or high-frequency local field potential power. Speech synthesis was performed using the 'Brai is a promising direction for speech BCIs.The ability to decode speech using intracortical electrode array signals from a nontraditional speech area suggests that placing electrode arrays in ventral speech areas is a promising direction for speech BCIs.Drug development has long included the systematic exploration of various resources. Among these, natural products are one of the most important resources from which novel agents are developed due to the multiple pharmacologic effects of these natural products on diseases. Tanshinone, a representative natural product, is the main compound extracted from the dried root and rhizome of Salvia miltiorrhiza Bge. Research on tanshinone began in the early 1930s. With the in-depth investigation of an increasing number of identified analogs, tanshinone has demonstrated a wide variety of bioactivities and contradicted the saying, 'You can't teach an old dog new tricks'. This review is focused on the pharmacological action of tanshinone and status of research on tanshinone in recent years. The mechanism of tanshinone has also drawn much attention, with the findings of representative targets and pathways of tanshinone. The most recent studies have comprehensively shown that tanshinone can be used to treat leukemia and solid carcinoma, protect against cardiovascular and cerebrovascular diseases, and alleviate liver- and kidney-related diseases, among its other effects. Multiple signaling pathways, including antiproliferative, antiapoptotic, anti-inflammatory, and antioxidative stress pathways, are involved in its actions. Diabetes-related foot ulcers give rise to considerable morbidity, generate a high monetary cost for health and social care services and precede the majority of diabetes-related lower extremity amputations. There are many clinical prediction rules in existence to assess risk of foot ulceration but few have been subject to validation. Our objectives were to produce an evidence-based clinical pathway for risk assessment and management of the foot in people with diabetes mellitus to estimate cost-effective monitoring intervals and to perform cost-effectiveness analyses and a value-of-information analysis. We developed and validated a prognostic model using predictive modelling, calibration and discrimination techniques. An overview of systematic reviews already completed was followed by a review of randomised controlled trials of interventions to prevent foot ulceration in diabetes mellitus. A review of the health economic literature was followed by the construction of an economic model, an analysis of the (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 24, No. 62. See the NIHR Journals Library website for further project information.Snakebites continue to be a public health concern in sub-Saharan Africa, where availability of appropriate medical treatment is rare, even though death and disability can be prevented with timely intervention. A challenge is the lack of sociopolitical studies to inform health policies. This study aimed to identify snakebite patient profiles, healthcare workers' (HCWs) knowledge of snakebite, and facilities' snakebite treatment capacity in Kenya, Uganda, and Zambia to inform interventions to improve access to appropriate treatment. The research comprised a cross-sectional key informant survey among HCWs from health facilities in Kenya (n = 145), Uganda (n = 144), and Zambia (n = 108). Data were collected between March 2018 and November 2019. Most of the HCWs suggested that the number of snakebite incidents was similar between the genders, that most patients were aged 21-30 years, and most people were bitten when farming or walking. Overall, only 12% of HCWs had received formal training in snakebite management.